Everest Biotech
2000
FOUNDED
M&A
STATUS
Buyout/LBO
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Producer of antibodies based in the UK. The company offers thousands of goat antibodies against a broad range of human, mouse and rat proteins of biomedical interest and specializes in antigen affinity purified goat polyclonal.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Parent Company
Primary Office
- Cherwell Innovation Centre
- 77 Heyford Park
- Upper Heyford OX25 5HD
- England, United Kingdom
+44 01869 000000
Everest Biotech Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Everest Biotech‘s full profile, request access.
Request full access to PitchBookEverest Biotech Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Monika Mobley | Chief Executive Officer | ||
| Ravindra Sapkota Ph.D | Co-Founder | ||
| Nicholas Hutchings | Co-Founder |
Everest Biotech Board Members (2)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 0000000 0000000 | LifeSpan BioSciences | Board Member | 000 0000 | |
| 000000 000000 | Everest Biotech | Board Member | 000 0000 |